Noble Capital Starts MAIA Biotechnology (MAIA) at Outperform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
- S&P 500 rises; Apple and Palantir set to report results
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 7% as Iran signals openness to peace talks
- Why has the market become so unforgiving of AI earnings?
- EchoStar rises on report SpaceX in talks to buy Boost Mobile or tap its network
Tweet
Share
E-mailGet Alerts MAIA Hot Sheet
Price: $1.11 +0.91%
Rating Summary:
1 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 21 | Down: 24 | New: 16
Rating Summary:
1 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 21 | Down: 24 | New: 16
Join SI Premium – FREE
Noble Capital analyst Robert LeBoyer initiates coverage on MAIA Biotechnology (NYSE: MAIA) with a Outperform rating and a price target of $14.00.
For an analyst ratings summary and ratings history on MAIA Biotechnology click here. For more ratings news on MAIA Biotechnology click here.
Shares of MAIA Biotechnology closed at $4.53 yesterday.
You May Also Be Interested In
- BTIG Starts SharkNinja (SN) at Buy
- H.C. Wainwright Assumes Nkarta Inc. (NKTX) at Buy
- JPMorgan Starts Saab AB (SAABB:SS) (SAABF) at Neutral
Create E-mail Alert Related Categories
Hot New Coverage, New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
